David L. Moyes

The paper investigates how isoleucine and asparagine affect the growth of staphylococcal strains in atopic dermatitis, finding they promote S. aureus growth and inhibit S. hominis growth.

This study tracks the development and microevolution of the oral microbiome during implant colonization, revealing niche-specific succession and strain-level genetic changes.

This study identifies a metabolic-epigenetic mechanism in oral epithelial cells that enhances protection against fungal infection through proline catabolism and mitochondrial function.

This study investigates microbiome signatures in the oral-gut-brain axis and their role in Parkinson's disease and cognitive decline.

The paper develops and evaluates optimized computational and experimental methods for analyzing the human mycobiome, identifying novel fungal species in oral and gut samples.

This study shows that Candida albicans promotes melanoma aggressiveness by activating p38-MAPK and HIF-1α pathways and inducing metabolic reprogramming.

Palidis identifies novel insertion sequences in metagenomic data by detecting inverted terminal repeats, revealing 519 previously uncharacterized sequences across 264 human metagenomes.

The paper identifies metabolic differences between Candida species using genomic, metabolomic, and gene expression data, highlighting unique pathways in the AGAu cluster.

The paper profiles and compares the phageome of oral and gut sites across individuals, finding distinct phage compositions and high diversity in oral sites, particularly on the tongue.